A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

N/ANot Yet RecruitingNCT06809647

PLU Ophthalmic10 enrolled

Overview

The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Glaucoma Open-Angle

Interventions

Glaucoma surgeryDEVICE

This is an implant-free, minimally invasive glaucoma surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Moderate to severe open angle glaucoma * Central corneal thickness between 480 and 610 microns Exclusion Criteria: * surgical history of corneal graft * presence of corneal opacities * Failed prior trabeculectomy

Locations (1)

MUSC Storm Eye Institute

Charleston, South Carolina, United States

Outcomes

Primary Outcomes

Intra Ocular pressure

Time frame: 12 months

Use of concomitant topical glaucoma medications

Time frame: 12 months

Central Contacts

Carlos A Urrea, MD

CONTACT

215-327-5500 CUrrea@pluophthalmic.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.